8 April 2023
RNZ's Kim Hill speaks to a participant in our CAR T-cell clinical trial, poet Michele Leggott.
Michele Leggott's latest book of poetry, Face to the Sky, explores her encounter with 19th-century New Zealand botanical artist Emily Cumming Harris.
But there's more to this story - Michele was battling non-Hodgkin's lymphoma while working on the book.
In early 2020, Michele received her diagnosis, just as the Covid-19 lockdowns began. Chemotherapy, radiotherapy, and a stem cell transplant in 2021 failed to cure her cancer. Finally, in early 2022, Michele was able to participate in a CAR T-cell therapy trial at the Malaghan Institute in Wellington.
"This is the future ... The Malaghan trial, the goal of that is to get publicly funded CAR T in this country so that you don't have to be on a trial to get it. If that can happen, it'll bring down hospital costs, you'll save lives."
Related articles
A ground-breaking cancer treatment is within reach – but only if New Zealand acts now
12 February 2026
Homegrown Hope - Stuff's series on CAR T-cell therapy
11 February 2026
Tracking the journey of the shapeshifting bacteria behind stomach cancer
19 November 2025
Celebrating milestones in bringing life-saving cell therapies to New Zealand
12 November 2025
Marsden funding to drive discovery and innovation in cancer, allergy and infectious disease research
5 November 2025
Eradicating H. Pylori bacterial infection to reduce stomach cancer
30 October 2025